Nilsson, Ida A. K. http://orcid.org/0000-0002-7676-4299
Millischer, Vincent http://orcid.org/0000-0003-1919-9649
Karrenbauer, Virginija Danylaité
Juréus, Anders
Salehi, Alireza M.
Norring, Claes http://orcid.org/0000-0002-9459-7279
von Hausswolff-Juhlin, Yvonne
Schalling, Martin
Blennow, Kaj
Bulik, Cynthia M.
Zetterberg, Henrik
Landén, Mikael
Funding for this research was provided by:
Stockholms Läns Landsting (20170058)
Karolinska Institutet
Hjärnfonden
Vetenskapsrådet (#2017-00915, 538-2013-8864, #2018-02532)
Klarman Family Foundation
Article History
Received: 6 March 2019
Accepted: 20 June 2019
First Online: 1 August 2019
Conflict of interest
: H.Z. has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed, and CogRx, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all unrelated to the submitted work). M.L. declares that, over the past 36 months, he has received lecture honoraria from Lundbeck pharmaceutical. C.M.B. reports: Shire (grant recipient, Scientific Advisory Board member); Pearson and Walker (author, royalty recipient). No other equity ownership, profit-sharing agreements, royalties, or patent. V.D.K. reports: Stockholm County Council (grant recipient ALF 20160457); Biogen (recipient of grant and scholarship, PI for project sponsored by); Novartis (recipient of scholarship and lecture honoraria); Merc (Scientific Advisory Board member, recipient of lecture honoraria). K.B. has served as a consultant or at advisory boards for Alector, Alzheon, CogRx, Biogen, Lilly, Novartis, and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg (all unrelated to the work presented in this paper).